Gavi, the Vaccine Alliance, NEC Corporation, and Simprints Technology Ltd. have signed a memorandum of understanding on ...
Otsuka Chemical Co., Ltd has announced its acquisition on cefixime business from Astellas Pharma, Inc. on 5 June 2019,...
PeptiDream Inc., a public Kanagawa-based biopharmaceutical company, on 5 June 2019, announced a strategic partnership wi...
LPIXEL Inc., a leader in image analysis and processing technology in life science and medical research has announced the...
Takeda Pharmaceutical have became the first private sector company to announce a financial commitment to the Global Fund...
Thermo Fisher Scientific has announced that its Oncomine Dx Target Test CDx System has received reimbursement coverage f...
The CureApp nicotine-dependent treatment app is clinically proved as a higher rate of sustained smoking cessation (CAR) ...
Scientists successfully bioengineered human liver organoids that faithfully mimic key features of fatal liver disease in...
Beam Therapeutics and Bio Palette have announced an exclusive cross-license agreement around each companies’ base ...
PENTAX Medical, a leading provider of endo-imaging solutions, will soon celebrate the 100th anniversary of the foundatio...
Japanese multinational conglomerate company Hitachi has signed a contract with Himed Hospital Management (Xuzhou) C...
Japanese firm Chugai Pharmaceutical Co., Ltd. has announced the decision to construct a core research laboratory, C...
Researchers at Okayama University report in the journal Sensors and Actuators B: Chemical that terahertz radia...
Japan headquartered Menicon Co. has announced the launch of the Menicon Bloom Myopia Control Management System...
Japan based B dot Medical Inc. has announced that the company has initiated the development of an ultra-compact pro...
Chugai Pharmaceutical has announced that it has obtained regulatory approval for the humanized anti-human IL-6 receptor ...
Elekta (EKTA-B.ST) has announced that its Elekta Unity magnetic resonance radiation therapy system has been approved for...
Eisai Inc., the U.S. pharmaceutical subsidiary of Japan headquartered Eisai Co., Ltd., has announced the immediate appoi...
